The desire to understand the mode of action of the thyroid hormones has prompted a wealth of investigation since the turn of the century. Although the physiological effects of the thyroid secretions appear to be well established, there is no general agreement on their exact mechanism of action at the cellular or subcellular level.
Currently, investigators appear to be concerned mainly with the pursuit of three major hypotheses: that the thyroid hormones act on enzymes, interact with metal ions, or alter the properties of membranes. The following discussion will deal with the current status of these three phases of the problem.
ENZYMES
The possibility that the thyroid hormones exert their biological effects by specifically inhibiting or stimulating key enzymes has been most actively investigated. It was early shown (Rohrer, 1924) that the oxygen consumption of certain tissues excised from thyrotoxic animals is greater than normal. Because of the pronounced calorigenic effect of the hormones in vivo, most investigators have concentrated their efforts on those enzymes upon which the respiratory activity of the cell depends. Of these, the two enzymatic processes most extensively studied are those concerned with coupled oxidative phosphorylation and with succinate oxidation.
The suggestion that thyroid hormones might affect oxidative phosphorylation arose from the demonstration that 2,4-dinitrophenol (DNP) can uncouple phosphorylation from respiration (Loomis et al., 1948; Cross et al., 1949) . It is now clear, however, that the effects of thyroid hormones on metabolic processes can not be explained by an action identical to that of 2,4-dinitrophenol. For example, DNP can raise the BMR of a myxedematous patient to normal without correcting other manifestations of the disease. A decreased phosphorylating ability secondary to some other more general action of thyroxine is, however, possible. Both a partial uncoupling of oxidative phosphorylation and an increased ATP-ase activity of thyrotoxic mitochondria have, in fact, been demonstrated (Martius et al., 1951; Lardy et al., 1951; Smith et al., 1951; Maley, 1957) .
These effects of thyroid hormones on oxidative phosphorylation and ATP-ase activity have been duplicated in vitro using mitochondria isolated from normal animals (Lardy et al., 1951; Martius et al., 1951 Martius et al., , 1952 Smith et al., 1951; Klemperer, 1955; Maley, 1957) . This ability of the thyroid hormones to decrease phosphorylating ability and increase ATP-ase activity of mitochondria can not be taken as evidence that the hormone directly affects these enzymes. In both instances, it appears that the changes are secondary to a primary effect on the mitochondria themselves (see below). When the enzymes involved are isolated in digitonin extracts of mitochondria, thyroxine neither uncouples oxidative phosphorylation nor stimulates the activity of ATP-ase Cooper et al., 1957) . Further, an actual inhibition of ATP-ase activity in sonic extracts of mitochondria has recently been shown (Bronk, 1961) .
The other enzymatic process which has been most extensively studied in relation to thyroid function is that of the oxidation of succinate. It has been repeatedly shown that in the thyrotoxic animal there is an increased succinoxidase activity in those tissues whose total oxygen consumption is increased by the in vivo administration of thyroxine (Tipton et al., 1946a (Tipton et al., , 1946b Williams-Ashman, 1948a , 1948b Barker, 1955; Maley, 1957) . This ability of the thyroid hormones to stimulate the oxidation of succinate can also be demonstrated by the addition of thyroxine to various mitochon-drial preparations in vitro (Aloisi et al., 1941; Gemmill, 1952) . Thyroxine in vitro apparently acts to preserve the succinoxidase activity in such preparations rather than to increase the original activity (Kripke et al, 1956) . A number of suggestions have been advanced to explain this effect of thyroxine on succinate oxidation (Gemmill, 1952; Kripke et al., 1956; Estabrook et al., 1954; Wolff et al., 1957a) . These various hypotheses have been discussed in detail elsewhere (Tapley et al., 1962) . Since the enzyme complex involved is in the mitochondria, the alterations induced by thyroxine are adequately explained by the direct effect of thyroid hormones on the mitochondria themselves (see below).
The activities of more than 40 other enzymes have been reported to be altered by thyroid hormones in vivo or in vitro. The in vitro effects in some instances parallel the changes which have been noted in vivo, and in some instances do not. Of these many observations, several deserve special mention. A number of dehydrogenases have been inhibited by the in vitro addition of thyroxine (cf Wolff et al., 1957a Wolff et al., , 1957b Vallee et al., 1956 ). These will be discussed in the section on metals below. The enzyme TPNH-DPN transhydrogenase, which is located in the mitochondrial membrane, has been shown to be inhibited by thyroxine in vitro (Ball et al., 1957) . The suggestion that an inhibition of this enzyme might explain many of the actions of thyroxine is an attractive one, since it implies that the hormone might control the availability of pyridine nucleotides. However, attempts to demonstrate alterations in the activity of this enzyme in liver mitochondria of thyrotoxic and hypothyroid rats have been unsuccessful (Stein et al., 1959) . One further series of studies should be mentioned. Klebanoff (1959a Klebanoff ( , 1959b Klebanoff ( , 1960 has shown that thyroxine, as well as many other phenolic compounds, stimulates the oxidation of epinephrine, ascorbic acid, DPNH and other compounds by peroxidase and added hydrogen peroxide. The significance of these findings is at the present time obscure.
Stimulation is provided by many compounds which do not possess thyroxine-like activity in nivo, and under most circumstances the thyronine nucleus provides more potent stimulation than does thyroxine itself.
Although it has been accepted that the mode of action of certain hormones is a direct interaction with enzymes, in the case of thyroid hormones inconsistencies in the data are so fundamental that some investigators now seriously doubt whether a hormone-enzyme interaction is the basis for their action. For hormonal activity to be exerted on enzymes, it has been assumed that the effect would be mediated through acceleration or inhibition of a "pacemaker." The variety of enzymes affected by the in vivo administration of thyroxine makes it unlikely that altered activity of an appropriate "pacemaker" will be demonstrated. Further, it has been shown that many of the observed changes in enzyme activity are secondary to effects on vitamin metabolism, metal ions, or membranes. In addition, all the in vitro effects on enzymes have required for their demonstration concentrations of thyroxine 100 to 100,000 times greater than those found in the tissues. Although the concept of a direct regulation of enzyme activity by thyroid hormones must not be dismissed, it seems appropriate to consider in more detail the possibility that the observed effects on enzymes are secondary to primary effects upon metals or upon membranes.
METALS
Thyroxine forms complexes with a number of metal ions, such as CO ++ , Zn ++ , Mg+% Co ++ , Mn**, and Ca ++ (Gemmill, 1953; Lardy, 1954; Davis, 1957) . During the past several years, it has become apparent that some of the in vitro effects of thyroxine can be explained by an interaction of the hormone with essential metal ions in the medium.
The first metal-containing enzyme shown to be stimulated by thyroxine was ascorbic acid oxidase, a copper-containing enzyme obtained from squash (Gemmill, 1951) . Although it was at first felt that this stimula-tion was due to a direct action of thyroxine on the metal in the enzyme, it later became apparent that the stimulation resulted from a chelation by thyroxine of inhibitory metals in the medium (Frieden, 1952) .
The interaction between thyroid hormones and magnesium ions has been extensively investigated. The ability of Mg+ + to antagonize the uncoupling effect of thyroxine on oxidative phosphorylation (Bain, 1954) apparently is not due to the formation of an insoluble complex. Objection to such an explanation was raised when it was shown that the uncoupling effects of triiodothyronine, which does not form an insoluble complex with Mg+ + , is also antagonized by the addition of magnesium ions to the medium (Mudd et al., 1955) . The antagonism can, however, be explained by the effect of Mg ++ in preserving mitochondrial structure (Tapley, 1956 ).
The observations most suggestive of an interaction between thyroxine and a metalcontaining enzyme are those reported by Wolff et al., (1957b) . They demonstrated an inhibition by thyroxine and certain of its analogues of malic, glutamic, lactic, glyceraldehyde-3-phosphate, and yeast alcohol and glucose-6-phosphate dehydrogenases; all of these enzymes either contain or are dependent upon Zn ++ . However, efforts to demonstrate a direct interaction between the Zn ++ in the enzyme and thyroxine were not successful.
Thus, although a number of the in vitro effects of thyroxine result from an interaction of the hormone with essential metal ions in the medium, to date no evidence lias been advanced that there is a direct interaction between thyroxine and a metalcontaining enzyme. Further, it should be noted that no in vivo alteration of metal metabolism sufficient to explain the effects of the hormone has yet been demonstrated.
MEMBRANES
That some hormones may exert their physiological effects through an interaction with membranes appears clear from the demonstration by Levine and others that insulin alters the permeability of some cell membranes to certain sugars (cf Levine et al., 1955) . Although no evidence for an action of thyroid hormones on cell membranes has been obtained, a direct effect of the hormone on the mitochondrial membranes has been observed.
A number of substances of intracellular occurrence influence the morphology of mitochondria. Swelling can be produced by phosphate (Raaflaub, 1953) , calcium (Tapley, 1956) , free fatty acids (Lehninger et al., 1959) , and thyroxine (Tapley, 1956) . Heavy metals can cause swelling (Tapley, 1956) , suggesting the importance of -SH and -S-S-groups in the maintenance of mitochondrial morphology. On the other hand, the intracellular fluid contains many factors, such as a high soluble protein concentration, ATP, and Mg 1 "*, which are known to inhibit swelling in vitro.
An alteration in the morphology of mitochondria can be produced by thyroxine both in vitro and in vivo. Mitochondria isolated from thyroxine-treated rats have been shown to be more fragile than normal (Tapley, 1956) . In vitro, thyroxine causes swelling of mitochondria at 1(HM, a concentration within the physiological range . In vivo, changes are detectable in liver mitochondria following administration of as little as 3/j.g of thyroxine per day (Fairhurst et al., 1959) .
When it was suggested that the effect of thyroxine on oxidative phosphorylation probably results from its action on the mitochondrial membrane (Tapley, 1956) , two major objections prevented a consideration of the possibility that the mitochondria might be the in vivo locus of thyroxine action. First, the effect on mitochondria could be produced by thyroxine analogues of low in vivo potency, such as the D-isomer of thyroxine.
Secondly, thyroxine-induced swelling could not be reversed, and such an irreversible action seemed incompatible with hormonal activity. Both of these problems have now been clarified.
The ability of thyroxine to cause mitochondrial swelling is dependent upon the presence of the iodo-substituted diphenyl ether but independent of the composition of the side chain (Shaw et al., 1959) . On the other hand, physiological activity in vivo is profoundly altered by minor changes in the side-chain of thyroxine. This apparent discrepancy seems to have been resolved by the demonstration that analogues of thyroxine with altered side chains reach the peripheral tissues in much lesser concentrations than the parent compound (Tapley et al., 1959; Hatfield et al., 1960) . The failure of early investigators to show in vitro reversal of thyroxine-induced swelling was finally resolved by Chappell and Greville (1958) . They demonstrated that when swelling takes place in a medium of buffered NaCl or KC1 in the absence of sucrose, ATP readily brings about contraction of the mitochondria. Thyroxine-induced swelling was thus recognized as a physiologically reversible phenomenon. This observation has subsequently been confirmed (Lehninger, 1959) .
Some of the consequences of mitochondrial swelling induced in vitro are of interest. It was shown by Brenner-Holzach et al., (1954) that swelling is accompanied by a decrease in the intramitochondrial levels of ATP. In addition, considerable evidence has now accumulated to show that mitochondrial levels of DPN, DPNH, TPN, and TPNH are related to swelling (Hunter et al., 1955 (Hunter et al., , 1956 ). Hunter (1959) has shown that ATP can actually cause "rebinding" of DPN to swollen mitochondria. Further, thyroxine has been shown to produce an alteration in the rate at which protein "leaks" from the mitochondria (Emmelot et al., 1958; Greif, 1961) .
The significance of this effect of thyroxine on the morphology of mitochondria as far as intracellular processes in vivo are concerned must be largely a matter of speculation. Mitochondria are, however, the site of generation of most of the total cellular energy, and their ability to generate ATP is markedly dependent upon the maintenance of their structure. It seems reasonable that many of the effects of thyroxine on enzymes, both in vitro and in vivo, may be brought about by an action of the hormone on the mitochondria! membrane. Such an action, by altering the entry and exit of substances involved in respiratory activity and energy transfer, must of necessity result in profound alterations in the economy of the cell. An example of such an indirect action of thyroxine on extramitochondrial functions of the cell has been provided by the investigation of Sokoloff et al., (1961) . They demonstrated that thyroxine stimulates the synthesis of protein by microsomes, and that this stimulation was secondary to an effect on the mitochondria. Whether the microsomes themselves are altered in vivo by thyroxine administration remains undetermined. However, attempts to produce changes in the morphology of microsomes by the in vitro addition of thyroxine have so far been unsuccessful (Tapley et al., 1961) .
It is perhaps premature to suggest that the mitochondrial membrane is the primary locus of action of the thyroid hormone, but the wealth of data which has accumulated in the past seven years appears to be compatible with such a suggestion. The fact that there are changes in the activity of certain enzymes in the red blood cell (which contains no mitochondria) following in vivo administration of thyroxine (Johnson et al., 1961) is not incompatible with this suggestion. Such profound changes are induced by the hormone in overall mineral and vitamin metabolism that any altered enzyme activities in red blood cells may well be secondary to these changes (cf Horvath, 1957) .
